Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026)
Amarin Corp Plcuk (AMRN) posted quarterly Change in Inventory of -$12.3 million for Q1 2026, up 11.29% YoY from -$11.1 million in Q1 2025, and down 686.63% sequentially from $2.1 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Change in Inventory (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk has disclosed Change in Inventory across 15 years of filings, most recently posting -$12.3 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 11.29% year-over-year to -$12.3 million; the TTM figure through Mar 2026 stood at -$33.3 million (up 70.42% YoY), while the FY2025 annual figure was -$34.9 million, up 66.92% from the prior year.
- Change in Inventory slipped to -$12.3 million in Q1 2026, from $2.1 million in the prior quarter.
- Over the last five years, Change in Inventory for AMRN reached as high as $52.9 million in Q1 2022 and fell as low as -$67.2 million in Q4 2024.
- The 5-year median for Change in Inventory is -$12.7 million (2024), against an average of -$10.1 million.
- Annual changes were most pronounced in 2024 — Change in Inventory slumped 570.87% — and 2025, when it surged 103.12%.
- A 5-year view of Change in Inventory shows it stood at -$23.2 million in 2022, then jumped by 56.84% to -$10.0 million in 2023, then tumbled by 570.87% to -$67.2 million in 2024, then jumped by 103.12% to $2.1 million in 2025, then sank by 686.63% to -$12.3 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered -$12.3 million, $2.1 million, and -$17.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 431.00 Mn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 184.00 Mn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | -18.00 Mn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 52.00 Mn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Amarin Corp Plcuk | 5.17 Bn | 5.00 Bn | 17.77 Mn | -12.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.33 Mn |
| Mar 31, 2026 | -12.33 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Dec 31, 2025 | 2.10 Mn |
| Sep 30, 2025 | -17.02 Mn |
| Sep 30, 2025 | -17.02 Mn |
| Jun 30, 2025 | -6.06 Mn |
| Jun 30, 2025 | -6.06 Mn |
| Mar 31, 2025 | -13.89 Mn |
| Mar 31, 2025 | -13.89 Mn |
| Dec 31, 2024 | -67.24 Mn |
| Dec 31, 2024 | -67.24 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -18.80 Mn |
| Jun 30, 2024 | -18.80 Mn |
| Mar 31, 2024 | -6.73 Mn |
| Mar 31, 2024 | -6.73 Mn |
| Dec 31, 2023 | -10.02 Mn |
| Dec 31, 2023 | -10.02 Mn |